Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

By Robin Sawka, BioCentury Staff | Apr 10, 2020 | 1:24 AM GMT
Editor's note: Updated on Apr 10, 2020 at 1:40 AM GMT

Arix Bioscience plc (LSE:ARIX) announced a series of senior management departures. CEO Joe Anderson has stepped down as CEO of the healthcare and life science investment company along with two undisclosed members of the senior team. Chairman Jonathan Peacock and Art Pappas, a non-executive director, will step down at the

Read the full 500 word article

How to gain access

Continue reading with a
two-week free trial.